Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects
Authors:
- Paolo PetazziPPPaolo Petazzi
- Olga Caridad Jorge-TorresOJOlga Caridad Jorge-Torres
- Antonio GomezAGAntonio Gomez
- Iolanda ScognamiglioISIolanda Scognamiglio
- Jordi Serra-MusachJSJordi Serra-Musach
- Angelika MerkelAMAngelika Merkel
- Daniela GrasesDGDaniela Grases
- Clara XiolCXClara Xiol
- Mar O’callaghanMOMar O’callaghan
- Judith ArmstrongJAJudith Armstrong
- Manel EstellerManel Esteller
- Sonia GuilSGSonia Guil
Open Access
- 11 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1453
Abstract
Rett syndrome (RTT) is a severe neurodevelopmental disease caused almost exclusively by mutations to the MeCP2 gene. This disease may be regarded as a synaptopathy, with impairments affecting synaptic plasticity, inhibitory and excitatory transmission and network excitability. The complete understanding of the mechanisms behind how the transcription factor MeCP2 so profoundly affects the mammalian brain are yet to be determined. What is known, is that MeCP2 involvement in activity-dependent expression programs is a critical link between this protein and proper neuronal activity, which allows the correct maturation of connections in the brain. By using RNA-sequencing analysis, we found several immediate-early genes (IEGs, key mediators of activity-dependent responses) directly bound by MeCP2 at the chromatin level and upregulated in the hippocampus and prefrontal cortex of the Mecp2-KO mouse. Quantification of the IEGs response to stimulus both in vivo and in vitro detected an aberrant expression pattern in MeCP2-deficient neurons. Furthermore, altered IEGs levels were found in RTT patient’s peripheral blood and brain regions of post-mortem samples, correlating with impaired expression of downstream myelination-related genes. Altogether, these data indicate that proper IEGs expression is crucial for correct synaptic development and that MeCP2 has a key role in the regulation of IEGs.Keywords
Funding Information
- Health and Science Departments of the Catalan Government
- Catalan and the Spanish Associations for Rett Syndrome
This publication has 77 references indexed in Scilit:
- MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous SystemCell, 2012
- The role of NR4A transcription factors in memory formationBrain Research Bulletin, 2011
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences, 2009
- Activity-dependent regulation of inhibitory synapse development by Npas4Nature, 2008
- The molecular machinery of myelin gene transcription in Schwann cellsGlia, 2008
- Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting taskNeuroscience, 2008
- MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse NumberNeuron, 2007
- Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neuronsNeurobiology of Disease, 2007
- Arc/Arg3.1 Mediates Homeostatic Synaptic Scaling of AMPA ReceptorsNeuron, 2006
- Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNACell, 1992